Oncogene-derived peptides: a new class of tumor rejection antigens?
Gedde-Dahl
T
T
Institute of Transplantation Immunology, National Hospital, Oslo, Norway.
Olsen
B H
BH
Thorsby
E
E
Gaudernack
G
G
D000595:Amino Acid Sequence; D000911:Antibodies, Monoclonal / Q000276:immunology; D002999:Clone Cells; D011905:Genes, ras; D006681:HLA-D Antigens / Q000276:immunology*; D006682:HLA-DP Antigens / Q000276:immunology; D006683:HLA-DQ Antigens / Q000276:immunology; D006684:HLA-DR Antigens / Q000276:immunology; D006801:Humans; D016297:Mutagenesis, Site-Directed; D016283:Proto-Oncogene Proteins p21(ras) / Q000235:genetics / Q000276:immunology*; D011948:Receptors, Antigen, T-Cell / Q000235:genetics; D011994:Recombinant Proteins / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology / Q000502:physiology*
D000911:Antibodies, Monoclonal; D006681:HLA-D Antigens; D006682:HLA-DP Antigens; D006683:HLA-DQ Antigens; D006684:HLA-DR Antigens; D011948:Receptors, Antigen, T-Cell; D011994:Recombinant Proteins; C501009:HRAS protein, human; D016283:Proto-Oncogene Proteins p21(ras)